Browse promising studies and published articles the effects of cannabinoids on a vast range of health and wellness issues.

Exciting potential for applications of the hemp compound often referred to as CBD.

Anti-Inflammatory and Anti-Oxidant

Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid?

February 1, 2013, Read Full Study


Safety and side effects of cannabidiol, a Cannabis sativa constituent.

January 12, 2012, Read Full Study

Alzheimer's Association

The therapeutic potential of the phytocannabinoid cannabidiol for Alzheimer's disease.

April 28, 2017, Read Full Study


Cannabis use in patients with fibromyalgia: effect on symptoms relief and health-related quality of life.

April 21, 2011, Read Full Study


Cannabidiol, a non-psychotropic plant-derived cannabinoid, decreases inflammation in a murine model of acute lung injury: role for the adenosine A(2A) receptor.

January 12, 2012, Read Full Study


Expression of Cannabinoid Receptors in Human Osteoarthritic Cartilage: Implications for Future Therapies

January 14, 2016, Read Full Study


Pain processing, the endocannabinoid system, and migraines.

March 29, 2010, Read Full Study

Gut Health

Cannabidiol reduces intestinal inflammation through the control of neuroimmune axis.

December 6, 2011, Read Full Study


Therapeutic potential of cannabidiol against ischemia/reperfusion liver injury in rats.

May 22, 2014, Read Full Study

Parkinson's Disease and Huntington's Disease

Prospects for cannabinoid therapies in basal ganglia disorders.

January 1, 2014, Read Full Study

Hypertension and Glaucoma

Effect of sublingual application of cannabinoids on intraocular pressure: a pilot study.

October 15, 2006, Read Full Study


Cannabidiol attenuates cisplatin-induced nephrotoxicity by decreasing oxidative/nitrosative stress, inflammation, and cell death.

December 12, 2008, Read Full Study

- Cancer -

In Vitro Anticancer Activity of Plant-Derived Cannabidiol on Prostate Cancer Cell Lines

July 2, 2014, Read Full Study

COX-2 and PPAR-γ confer Cannabidiol induced apoptosis of human lung cancer cells.

December 7, 2012, Read Full Study

Decrease of plasminogen activator inhibitor-1 may contribute to the anti-invasive action of Cannabidiol on human lung cancer cells.

July 29, 2010, Read Full Study

Chemopreventive effect of non-psychotropic phytocannabinoid cannabidiol on experimental colon cancer.

Jan 12, 2010, Read Full Study

Cannabidiol inhibits angiogenesis by multiple mechanisms.

November 1, 2012, Read Full Study

Cannabidiol inhibits growth and induces programmed cell death in kaposi sarcoma-associated herpesvirus-infected endothelium.

July 3, 2012, Read Full Study

Cannabidiol-induced apoptosis in human leukemia cells: A novel role of Cannabidiol in the regulation of p22phox and Nox4 expression.

June 5, 2006, Read Full Study

Cannabidiol inhibits cancer cell invasion via upregulation of tissue inhibitor of matrix metalloproteinases-1.

November 13, 2009, Read Full Study

- Mental Health -

Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report.

September 9, 2010, Read Full Study

Cannabidiol for the treatment of cannabis withdrawal syndrome: a case report.

October 24, 2012, Read Full Study

Cannabidiol and clozapine reverse MK-801-induced deficits in social interaction and hyperactivity in Sprague-Dawley rats.

April 9, 2012, Read Full Study

Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patients.

February 9, 2011, Read Full Study

Anxiety, Sleep, and Schizophrenia: What Studies Say about Hemp CBD

November 18, 2014, Read Full Study

Transdermal delivery of cannabidiol attenuates binge alcohol-induced neurodegeneration in a rodent model of an alcohol use disorder

October 23, 2013, Read Full Study

Antidepressant-like and anxiolytic-like effects of cannabidiol: a chemical compound of Cannabis sativa.

January 1, 2014, Read Full Study

Antidepressant-like effect of delta9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L.

March 21, 2010, Read Full Study

Cannabidiol reduces cigarette consumption in tobacco smokers: preliminary findings.

April 1, 2013, Read Full Study

- Cardiovascular Health -

Is the cardiovascular system a therapeutic target for Cannabidiol?

February 13, 2013, Read Full Study

17Cannabidiol as an anti-arrhythmic, the role of the CB1 receptors

January 3, 2011, Read Full Study

The potential use of cannabidiol in the therapy of metabolic syndrome.

April 1, 2012, Read Full Study

Multiple intracranial aneurysms in elderly patients.

January 3, 1999, Read Full Study

Cannabinoids alter endothelial function in the Zucker rat model of type 2 diabetes.

October 8, 2013, Read Full Study

Acute administration of Cannabidiol in vivo suppresses ischaemia-induced cardiac arrhythmias and reduces infarct size when given at reperfusion.

June 9, 2010, Read Full Study

Cannabidiol Protects against Doxorubicin-Induced Cardiomyopathy by Modulating Mitochondrial Function and Biogenesis.

January 6, 2015, Read Full Study

- Diabetes -

Neuroprotective and blood-retinal barrier-preserving effects of cannabidiol in experimental diabetes.

January 4, 2006, Read Full Study

Cannabinoids and endocannabinoids in metabolic disorders with focus on diabetes.

January 5, 2011, Read Full Study

Cannabidiol arrests onset of autoimmune diabetes in NOD mice.

July 17, 2007, Read Full Study

Cannabidiol attenuates high glucose-induced endothelial cell inflammatory response and barrier disruption.

March 23, 2007, Read Full Study

The effect of cannabidiol on ischemia/reperfusion-induced ventricular arrhythmias: the role of adenosine A1 receptors.

May 22, 2014, Read Full Study

Cannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathy.

December 14, 2010, Read Full Study

Cannabidiol lowers incidence of diabetes in non-obese diabetic mice.

March 1, 2006, Read Full Study

- Multiple Sclerosis -

A Randomized Study of Sativex on Cognitive Function and Mood: Multiple Sclerosis Patients

May 2, 2014, Read Full Study

Multiple sclerosis subjects with a clinical diagnosis of central neuropathic pain entered a seven to ten day baseline period, followed by a four week double blind, randomized, parallel group comparison of "Sativex" and placebo.

June 24, 2013, Read Full Study

- Epilepsy -

Hypnotic and antiepileptic effects of cannabidiol.

September 2, 1981, Read Full Study

Cannabidiol exerts anti-convulsant effects in animal models of temporal lobe and partial seizures.

April 19, 2012, Read Full Study